Evidence map›Paper›PMID 42048450›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2026

HIV-1 infection induces Vif-mediated SUMOylation of host RNA splicing factors important for proper viral RNA splicing.

Demetra P Kelenis, Jeffrey R Johnson, Simone Sidoli, Ann Emery, Ronald Swanstrom, Luke J Hawkins, Kaila Mckie, Tegh Pawar, Stephen P Goff

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. HIV-1 Vif-dependent SUMOylation regulates viral RNA splicing.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Demetra P KelenisBiochemistry and Molecular Biophysics, Columbia University, New York, NY 10032.
Jeffrey R JohnsonMicrobiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029.
Simone SidoliBiochemistry, Albert Einstein College of Medicine, New York, NY 10461.ORCID 0000-0001-9073-6641
Ann EmeryLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.
Ronald SwanstromLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.ORCID 0000-0001-7777-0773
Luke J HawkinsBiochemistry and Molecular Biophysics, Columbia University, New York, NY 10032.
Kaila MckieBiochemistry and Molecular Biophysics, Columbia University, New York, NY 10032.
Tegh PawarBiochemistry and Molecular Biophysics, Columbia University, New York, NY 10032.
Stephen P GoffBiochemistry and Molecular Biophysics, Columbia University, New York, NY 10032.ORCID 0000-0002-9679-0582

Funding

Tumor Biology and Microenvironment ProgramP30CA013696 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Anil K Rustgi · 1985 to 2026
$115.3M
Center for Structural Biology of HIV RNAU54AI170660 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ALICE TELESNITSKY · 2022 to 2026
$32.1M
Development and application of a quantitive model for HIV-1 transcriptional activation driven by TAR RNA conformational dynamicsR01AI178848 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Hashim M Al-Hashimi, STEPHEN Paine GOFF · 2023 to 2026
$3.2M
Cellular Determinants and Function Consequences of PP2A-B56 Degradation by HIV-1 VifR01AI167691 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Jeffrey R Johnson · 2023 to 2026
$2.2M
Orbitrap Exploris 480 Basic SystemS10OD030286 · OD · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI SIDOLI, SIMONE · 2021 to 2021
$600k
Einstein-Mount Sinai Diabetes center NoneHevolution Foundation (AFAR) NoneHHS | NIH | NCI | Center for Cancer Research (CCR) P30CA013696HHS | NIH | NIAID | Division of Microbiology and Infectious Diseases (DMID) R01AI167691HHS | NIH | NIH Office of the Director (OD) S10OD030286NIAID NIH HHS R01 AI178848NIAID NIH HHS U54 AI170660UNC Comprehensive cancer center P30 CA16068UNC | UNC | Center for AIDS Research, University of North Carolina at Chapel Hill (UNC CFAR) P30 AI50410
6 · The paper itself

Abstract

SUMOylation is a dynamically regulated post-translational modification involving covalent attachment of small ubiquitin-like modifiers (SUMOs) to lysine residues of target proteins. SUMOylation modulates multiple fundamental host cellular pathways, including pathways hijacked by HIV-1 to enable replication, but has not been explored by large-scale proteomics in the context of HIV-1 infection. Here, we performed a proteome-wide, mass spectrometry-based screen to identify proteins that are SUMOylated in response to HIV-1 infection. We show that infection with HIV-1 leads to the widespread increased SUMOylation of the heterogeneous nuclear ribonucleoprotein (HNRNP) A/B family. This phenotype was driven by expression of HIV-1 Viral Infectivity Factor (Vif), suggesting an unexplored function for this protein. Depletion of HNRNP A/B proteins led to altered splicing of HIV-1 viral RNAs and dramatically reduced HIV-1 infectivity. Our data suggest a mechanism involving HIV-1-induced, Vif-mediated SUMOylation of host RNA splicing factors as a means to regulate HIV-1 alternative splicing.

Indexed as

HIV-1HIV InfectionsRNA SplicingRNA Splicing FactorsRNA, ViralSumoylationvif Gene Products, Human Immunodeficiency VirusHEK293 CellsHeterogeneous-Nuclear Ribonucleoprotein Group A-BHost-Pathogen InteractionsHumansHeterogeneous-Nuclear Ribonucleoprotein Group A-BRNA Splicing FactorsRNA, Viralvif Gene Products, Human Immunodeficiency VirusHIV-1HNRNPsplicingSUMOVif

Identifiers

PMID42048450
PMCPMC13142951

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.